Neurobiological influences on recovery from traumatic brain injury: The role of genetic polymorphisms

Current Pharmaceutical Design

Volumn 20, Issue 26, 2014, Pages 4275-4283

  Weaver, Starla M ^a   Portelli, Jaclyn N ^a  

^a KESSLER FOUNDATION   (United States)

Author keywords

Genes; Polymorphisms; Traumatic brain injury

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DIPEPTIDYL CARBOXYPEPTIDASE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; INTERLEUKIN DERIVATIVE; PROTEIN P53;

DOPAMINERGIC SYSTEM; GENETIC POLYMORPHISM; HUMAN; NEUROBIOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TRAUMATIC BRAIN INJURY; BRAIN INJURY; GENETICS;

BRAIN INJURIES; HUMANS; POLYMORPHISM, GENETIC; QUALITY OF LIFE;

EID: 84904738224     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Hyder AA, Wunderlich CA, Puvanachandra P, Gururaj G, Kobusingye OC. The impact of traumatic brain injuries: a global perspective. Neuro Rehabil 2007; 22: 341-53
2. Brennan FH, Anderson AJ, Taylor SM, Woodruff TM, Ruitenberg MJ. Complement activation in the injured central nervous system: another dual-edged sword? J Neuroinflammation 2012; 9: 137
3. Ling GSF, Marshall SA. Management of traumatic brain injury in the intensive care unit. Neurol Clin 2008; 26: 409-26
4. Kraus JF, McArthur DL. Incidence and prevalence of, and costs associated with, traumatic brain injury, in Rehabilitation of the Adult and Child With Traumatic Brain Injury, 3rd ed. Edited by Rosenthal M, Griffith ER, Kreutzer JS, et al. Philadelphia, FA Davis Company 1999; pp: 3-18
5. Rao V, Lyketsos C. Neuropsychiatric sequelae of traumatic brain injury. Psychosomatics 2000; 41: 95-103
6. McAllister TW. Neurobehavioral sequelae of traumatic brain injury: evaluation and management. World Psychiatry 2008; 7: 3-10
7. Liss M, Willer B. Traumatic brain injury and marital relationships: a literature review. Int J Rehabil Res 1990; 13: 309-20
8. Thomsen IV. Late outcome of very severe blunt head trauma: a 10-15 year second follow-up. J Neurol Neurosurg Psychiatry 1984; 47: 260-8
9. Hoofien D, Gilboa A, Vakil E, Donovick PJ. Traumatic brain injury (TBI) 10-20 years later: a comprehensive outcome study of psychiatric symptomatology, cognitive abilities, and psychosocial functioning. Brain Inj 2001; 3: 189-209
10. Mazaux JM, Masson F, Levin HS, Alaoui P, Maurette P, Barat M. Long-term neuropsychological outcome and loss of social autonomy after traumatic brain injury. Arch Phys Med Rehabil 1997; 78: 1316-20
11. Tiesman H, Young T, Torner JC, McMahon M, Peek-Asa C, Fiedler J. Effects of a rural trauma system on traumatic brain injuries. J Neurotrauma 2007; 24: 1189-97
12. Whitmore RG, Thawani JP, Grady MS, Levine JM, Sanborn MR, Stein SC. Is aggressive treatment of traumatic brain injury costeffective? J Neurosurg 2012; 116: 1106-13
13. Raymont V, Greathouse A, Reding K, Lipsky R, Salazar A, Grafman J. Demographic, structural and genetic predictors of late cognitive decline after penetrating head injury. Brain 2008; 131(Pt 2): 543-58
14. Green RE, Colella B, Christensen B, et al. Examining moderators of cognitive recovery trajectories after moderate to severe traumatic brain injury. Arch Phys Med Rehabilt 2008; 89: S16-24
15. Hanks RA, Rapport LJ, Wertheimer J, Koviak C. Randomized controlled trial of peer mentoring for individuals with traumatic brain injury and their significant others. Arch Phys Med Rehabil 2012; 93: 1297-304
16. Weaver SM, Chau A, Portelli JN, Grafman J. Genetic polymorphisms influence recovery from traumatic brain injury. Neuroscientist 2012; 18: 631-44
17. McAllister TW. Polymorphisms in genes modulating the dopamine system: do they influence outcome and response to medication after traumatic brain injury? J Head Trauma Rehabil 2009; 24: 65-8
18. Dardiotis E, Grigoriadis S, Hadjigeorgiou GM. Genetic factors influencing outcome from neurotrauma. Curr Opin Psychiatry 2012; 25: 231-8
19. Schultz W. Behavioral dopamine signals. Trends Neurosci 2007; 30: 203-10
20. Bales JW, Kline AE, Wagner AK, Dixon CE. Targeting Dopamine in Acute Traumatic Brain Injury. Open Drug Discov J 2010; 2: 119-28
21. Bales JW, Wagner AK, Kline AE, Dixon CE. Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis. Neurosci Biobehav Rev 2009; 33: 981-1003
22. Frenette AJ, Kanji S, Rees L, et al. Efficacy and safety of dopamine agonists in traumatic brain injury: a systematic review of randomized controlled trials. J Neurotrauma 2012; 29: 1-18
23. Dickinson D, Elvevåg B. Genes, cognition and brain through a COMT lens. Neuroscience 2009; 164: 72-87
24. Rainer G, Asaad WF, Miller EK. Selective representation of relevant information by neurons in the primate prefrontal cortex. Nature 1998; 393: 577-9
25. Wagner AD, Maril A, Bjork RA, Schacter DL. Prefrontal contributions to executive control: fMRI evidence for functional distinctions within lateral Prefrontal cortex. Neuroimage 2001; 14: 1337-47
26. Redell JB, Dash PK. Traumatic brain injury stimulates hippocampal catechol-O-methyl transferase expression in microglia. Neurosci Lett 2007; 413: 36-41
27. Lipsky RH, Sparling MB, Ryan LM, et al. Association of COMT Val158Met genotype with executive functioning following traumatic brain injury. J Neuropsychiatry Clin Neurosci 2005; 17: 465-71
28. Horn AS. Dopamine uptake: a review of progress in the last decade. Prog Neurobiol 1990; 34: 387-400
29. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 1998; 95: 4029-34
30. Wagner AK, Ren D, Conley YP, et al. Sex and genetic associations with cerebrospinal fluid dopamine and metabolite production after severe traumatic brain injury. J Neurosurg 2007; 106: 538-47
31. McAllister TW, Rhodes CH, Flashman LA, McDonald BC, Belloni D, Saykin AJ. Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury. Am J Psychiatry 2005; 162: 1749-51
32. McAllister TW, Flashman LA, Harker Rhodes C, et al. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. Brain Inj 2008; 22: 705-14
33. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622-30
34. Mahley RW, Huang Y, Weisgraber KH. Putting cholesterol in its place: apoE and reverse cholesterol transport. J Clin Invest 2006; 116: 1226-9
35. Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 2006; 103: 5644-51
36. Adibhatla RM, Hatcher JF, Altered lipid metabolism in brain injury and disorders. Subcell Biochem 2008; 49: 246-68
37. Dardiotis E, Fountas KN, Dardioti M, et al. Genetic association studies in patients with traumatic brain injury. Neurosurg Focus 2010; 28: E9
38. Sorbi S, Nacmias B, Piacentini S, et al. ApoE as a prognostic factor for post-traumatic coma. Nat Med 1995; 1: 852
39. Ost M, Nylén K, Csajbok L, et al. Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury. Acta Anaesthesiol Scand 2008; 52: 1364-9
40. Brichtová E, Kozák L. Apolipoprotein E genotype and traumatic brain injury in children-association with neurological outcome. Childs Nerv Syst 2008; 24: 349-56
41. Alexander S, Kerr ME, Kim Y, Kamboh MI, Beers SR, Conley YP. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. J Neurotrauma 2007; 24: 790-7
42. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350: 1069-71.
43. Diaz-Arrastia R, Gong Y, Fair S, et al. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol 2003; 60: 818-22
44. Teasdale GM, Murray GD, Nicoll JA. The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study. Brain 2005; 128: 2556-61
45. Ponsford J, Rudzki D, Bailey K, Ng KT. Impact of apolipoprotein gene on cognitive impairment and recovery after traumatic brain injury. Neurology 2007; 68: 619-20
46. Han SD, Drake AI, Cessante LM, et al. Apolipoprotein E and traumatic brain injury in a military population: evidence of a neuropsychological compensatory mechanism? J Neurol Neurosurg Psychiatry 2007; 78: 1103-8
47. Willemse-van Son AH, Ribbers GM, Hop WC, van Duijn CM, Stam HJ. Association between apolipoprotein-epsilon4 and longterm outcome after traumatic brain injury. J Neurol Neurosurg Psychiatry 2008; 79: 426-30
48. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA. Metaanalysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma 2008; 25: 279-90
49. Ponsford J, McLaren A, Schonberger M, et al. The assocation between apolipoprotein E and traumatic brain injury severity and functional outcome in a rehabilitation sample. J Neurotrauma 2011; 28: 1683-92
50. Sadigh-Eteghad S, Talebi M, Farhoudi M. Association of apolipoprotein E epsilon 4 allele with sporadic late onset Alzheimer's disease. A meta-analysis. Neurosciences (Riyadh) 2012; 17: 321-6
51. Starkstein SE, Jorge R. Dementia after traumatic brain injury. Int Psychogeriatr 2005; 17 Suppl 1: S93-107
52. Nicoll JA, Roberts GW, Graham DI. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1995; 1: 135-7
53. Mayeux R, Ottman R, Maestre G, et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology 1995; 45: 555-7
54. Mehta KM, Ott A, Kalmijn S, et al. Head trauma and risk of dementia and Alzheimer's disease: The Rotterdam Study. Neurology 1999; 53: 1959-62
55. Millar K, Nicoll JA, Thornhill S, Murray GD, Teasdale GM. Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry 2003; 74: 1047-52
56. Moretti L, Cristofori I, Weaver SM, Chau A, Portelli JN, Grafman J. Cognitive decline in older adults with a history of traumatic brain injury. Lancet Neurol 2012; 11: 1103-12
57. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22: 123-31.
58. Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behav Pharmacol 2010; 21: 427-37
59. Griesbach GS, Hovda DA, Molteni R, Gomez-Pinilla F. Alterations in BDNF and synapsin I within the occipital cortex and hippocampus after mild traumatic brain injury in the developing rat: reflections of injury-induced neuroplasticity. J Neurotrauma 2002; 19: 803-14
60. Gao X, Smith GM, Chen J. Impaired dendritic development and synaptic formation of postnatal-born dentate gyrus granular neurons in absence of brain-derived neurotrophic factor signaling. Exp Neurol 2009; 215: 178-90
61. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-5
62. Galvin KA, Oorschot DE. Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: a stereological study. Neuroscience 2003; 118: 1023-32
63. Blaha GR, Raghupathi R, Saatman KE, McIntosh TK. Brainderived neurotrophic factor administration after traumatic brain injury in the rat does not protect against behavioral or histological deficits. Neuroscience 2000; 99: 483-93
64. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25: 295-301
65. Griesbach GS, Hovda DA, Molteni R, Wu A, Gomez-Pinilla F. Voluntary exercise following traumatic brain injury: brain-derived neurotrophic factor upregulation and recovery of function. Neuroscience 2004; 125: 129-39
66. McAllister TW, Tyler AL, Flashman LA, et al. Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury. J Neurotrauma 2012; 29: 1111-8
67. Kleim JA, Chan S, Pringle E, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci 2006; 9: 735-7
68. Sanchez MM, Das D, Taylor JL, Noda A, Yesavage JA, Salehi A. BDNF polymorphism predicts the rate of decline in skilled task performance and hippocampal volume in healthy individuals. Transl Psychiatry 2011; 1: e51
69. Dempster E, Toulopoulou T, McDonald C, et al. Association between BDNF val66 met genotype and episodic memory. Am J Med Genet B Neuropsychiatr Genet 2005; 134B: 73-5
70. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003; 112: 257-69
71. Siironen J, Juvela S, Kanarek K, Vilkki J, Hernesniemi J, Lappalainen J. The Met allele of the BDNF Val66Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke 2007; 38: 2858-60
72. Lanctôt KL, Rapoport MJ, Chan F, et al. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury. Brain Inj 2010; 24: 959-69
73. Krueger F, Pardini M, Huey ED, et al. The role of the Met66 brainderived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury. J Neurosci 2011; 3: 598-606
74. Bagnato S, Minafra L, Bravatà V, et al. Brain-derived neurotrophic factor (Val66Met) polymorphism does not influence recovery from a post-traumatic vegetative state: a blinded retrospective multicentric study. J Neurotrauma 2012; 29: 2050-9
75. Rostami E, Krueger F, Zoubak S, et al. BDNF polymorphism predicts general intelligence after penetrating traumatic brain injury. PLoS One 2011; 6: e27389
76. Duprez DA. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 2006; 24: 983-91
77. Kehoe AD, Eleftheriou KI, Heron M, Coats TJ, Montgomery HE. Angiotensin-converting enzyme genotype may predict survival following major trauma. Emerg Med J 2008; 25: 759-61
78. Tiret L, Rigat B, Visvikis S, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin Iconverting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205
79. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin Iconverting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6
80. Amouyel P, Richard F, Cottel D, Amant C, Codron V, Helbecque N. The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment. Neurosci Lett 1996; 217: 203-5
81. Richard F, Berr C, Amant C, Helbecque N, Amouyel P, Aperovitch A. Effect of angiotensin I-converting enzyme I/D polymorphism on cognitive decline. Neurobiol Aging 2000; 21: 75-80
82. Richard F, Fromentin-David I, Ricolfi F, et al. The angiotensin I converting enzyme gene as a susceptibility factor for dementia. Neurology 2001; 56: 1593-5
83. Hassan A, Lansbury A, Catto AJ, et al. Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes. J Neurol Neurosurg Psychiatry 2002; 72: 343-6
84. Sayed-Tabatabei FA, Houwing-Duistermaat JJ, van Duijn CM, Witteman JC. Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis. Stroke 2003; 34: 1634-9
85. Ariza M, del Matarin M, Junqué C, et al. Influence of angiotensinconverting enzyme polymorphism on neuropsychological subacute performance in moderate and severe traumatic brain injury. J Neuropsychiatry Clin Neurosci 2006; 18: 39-44
86. Morganti-Kossmann MC, Rancan M, Stahel PF, Kossmann T. Inflammatory response in acute traumatic brain inury: a doubleedged sword. Curr Opin Crit Care 2002; 8: 101-5
87. Jordan BD. Genetic influences on outcome following traumatic brain injury. Neurochem Res 2007; 32: 905-15
88. Uzan M, Tanriverdi T, Baykara O, et al. Association between interleukin-1 beta (IL-1beta) gene polymorphism and outcome after head injury: an early report. Acta Neurochir 2005; 147: 715-20
89. Hadjigeorgiou GM, Paterakis K, Dardiotis E, et al. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology 2005; 65: 1077-82
90. Tanriverdi T, Uzan M, Sanus GZ, et al. Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury. Surg Neurol 2006; 65: 7-10
91. Dardiotis E, Dardioti M, Hadjigeorgiou GM, Paterakis K. Re: Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury. Surg Neurol 2006; 66: 334-5
92. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47: 195-8.
93. Winter CD, Pringle AK, Clough GF, Church MK. Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 2004; 127: 315-20
94. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O'Keefe GE. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock 2003; 20: 218-23
95. Dalla Libera AL, Regner A, de Paoli J, Centenaro L, Martins TT, Simon D. IL-6 polymorphism associated with fatal outcome in patients with severe traumatic brain injury. Brain Inj 2011; 25: 365-9
96. Miñambres E, Cemborain A, Sánchez-Velasco P, et al. Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med 2003; 31: 933-8
97. Raghupathi R, Graham DI, McIntosh TK. Apoptosis after traumatic brain injury. J Neurotrauma 2000; 17: 927-38
98. Raghupathi R. Cell death mechanisms following traumatic brain injury. Brain Pathol 2004; 14: 215-22
99. Ara S, Lee PS, Hansen MF, Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 1990; 18: 4961
100. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 2003; 33: 357-65
101. Martínez-Lucas P, Moreno-Cuesta J, García-Olmo DC, et al. Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med 2005; 31: 1168-73
102. Sabol SZ, Hu S, Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103: 273-9
103. Pardini M, Krueger F, Hodgkinson C, et al. Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury. Neurology 2011; 76: 1038-45
104. Carter M, Miller M, Burkhardt J, et al. Variants of SLC6A4 and BDNF in depression risk and onset following severe TBI. J Neurotrauma 2011; 28: A14.
105. Robertson CS, Gopinath SP, Valadka AB, Van M, Swank PR, Goodman JC. Variants of the endothelial nitric oxide gene and cerebral blood flow after severe traumatic brain injury. J Neurotrauma 2001; 28: 727-37
106. Bales J, Garringer J, Conley Y, et al. Association between the PPP3CC gene, coding for the Calcineurin gamma catalytic subunit, and severity of traumatic brain injury in humans. J Neurotrauma 2011; 28: A101
107. McDevitt JK, Tierney RT, Mansell JL, et al. Neuronal structural protein polymorphism and concussion in college athletes. Brain Inj 2011; 25: 1108-13.
108. Hatz L, Scanlon J, Miller M, et al. KIBRA polymorphism associations with episodic memory in a TBI population. J Neurotrauma 2011; 28: A101-2
109. Bonham JR. Impact of new screening technologies: should we screen and does phenotype influence this decision? J Inherit Metab Dis. in press
110. Pal T, Vadaparampil ST. Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting. Cancer Control 2012; 19: 255-66
111. Exner DV, Dries DL, Domanski MJ, Cohn JN. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 2001; 344: 1351-7
112. Common genetic variation and antidespressent efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. Am J Psychiatry 2013; 170: 207-17
113. Kozlowski O, Cortet-Rudelli C, Yollin E, Merlen E, Daveluy W, Rousseaux M. Growth hormone replacement therapy in patients with traumatic brain injury. J Neurotrauma. in press
114. De los Reyes Aragón CJ, Arango-Lasprilla JC, Perea Bartolomé M, Ladera Fernández V, Krch D. The effect of cognitive impairment on self-generation in Hispanics with TBI. NeuroRehabilitation 2012; 30: 55-64
115. Conley YP, Alexander S. Genomic, transcriptomic, and epigenomic approaches to recovery after acquired brain injury. PM R 2011; 3: S52-8
116. Comings D E. Why different rules are required for polygenic inheritance: Lessons from studies of the DRD2 gene. Alcohol 1998; 1: 61-70
117. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010; 167: 509-27.